From Nasdaq: 2025-04-01 18:15:00

DaVita HealthCare (DVA) closed at $151.91, down -0.69% from the previous day. Shares rose 6.9% in the past month, outperforming the Medical sector and S&P 500. Earnings are projected at $1.75 per share, a 26.47% drop from last year. Revenue is estimated at $3.23 billion, a 5.27% increase from last year.

Analysts expect DaVita HealthCare’s full-year earnings to be $10.76 per share and revenue to be $13.47 billion, representing +11.16% and +5.08% changes, respectively. Recent analyst estimates suggest confidence in the company’s performance. DaVita HealthCare holds a Zacks Rank #3 (Hold) with a Forward P/E ratio of 14.21.

The Medical – Outpatient and Home Healthcare industry, to which DaVita HealthCare belongs, has a Zacks Industry Rank of 46, in the top 19% of all industries. Zacks research indicates top-rated industries outperform the bottom half 2 to 1. Stay updated on stock metrics using Zacks.com for informed trading decisions.

Zacks Investment Research has identified 7 elite stocks as the “Most Likely for Early Price Pops.” These stocks have outperformed the market, averaging +23.9% per year since 1988. Investors are advised to give these handpicked stocks immediate attention for potential gains. Follow the link for the latest recommendations from Zacks Investment Research.



Read more at Nasdaq: DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know